TrialJournal for immunotherapy of cancer2024

Impact of select actionable genomic alterations on efficacy of neoadjuvant immunotherapy in resectable non-small cell lung cancer.

Nicolas Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.